Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Fabtech Technologies Limited, (The Company) solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities and shall n
Why Turnkey + In-House Manufacturing Matters o In pharmaceutical, biopharma, and healthcare projects, choosing a turnkey partner with in-house Process, Air & Water manufacturing capabilities is no longer a preference, it is a strategic necessity. o Single Accountability, Zero Coordination Risk: One
Slide 5: Global Turnkey Solutions Provider to the Life Sciences & Healthcare Sectors
Global Turnkey Solutions Provider to the Life Sciences & Healthcare Sectors Fabtech Technologies Limited (FTL), the flagship of the Fabtech Group, brings three decades of engineering excellence to deliver start-to-finish turnkey solutions for pharmaceutical, biotech, and healthcare facilities worldw
Slide 6: Order Book & Strategic Update
Order Book & Strategic Update Strong Order Book Position • Consolidated order book ₹900 + Crore as of March 31, 2026 • Provides strong revenue visibility and growth momentum Strengthening Global Positioning • Expanding presence in high-growth sectors & geographies • Building a scalable and diversifi
Slide 7: Strategic Project Wins Across High-Growth Markets
Strategic Project Wins Across High-Growth Markets Fabtech continues to strengthen its global execution platform through high-value projects in Africa and Saudi Arabia, while expanding into high-potential sectors such as vaccines, animal health, and pharmaceutical manufacturing. The consolidated orde